This data also shed light on the quaternary structure of the protein that may impact the function(s) of PFN-1 and could partly explain the toxic gain/loss-of-function as the mechanisms in the neurodegeneration in ALS. The gene discussed is PFN1; the disease is amyotrophic lateral sclerosis.